Adults with ADHD: Use and misuse of stimulant medication as reported by patients and their primary care physicians

ADHD Attention Deficit and Hyperactivity Disorders

Volumn 5, Issue 4, 2013, Pages 369-376

  Lensing, Michael B ^a   Zeiner, Pål ^b   Sandvik, Leiv ^b   Opjordsmoen, Stein ^b,c  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Adult ADHD; Misuse; Physician patient agreement; Primary care physician; Stimulant medication

Indexed keywords

AMPHETAMINE; ATOMOXETINE; CENTRAL STIMULANT AGENT; METHYLPHENIDATE;

ADULT; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; DEPRESSION; DRUG MISUSE; DRUG THERAPY; DRUG USE; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; QUESTIONNAIRE; SHEEHAN DISABILITY SCALE; SUICIDAL BEHAVIOR;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS, PRIMARY CARE; QUESTIONNAIRES; SELF MEDICATION; SELF REPORT; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84891121139     PISSN: 18666116     EISSN: 18666647     Source Type: Journal    
DOI: 10.1007/s12402-013-0116-8     Document Type: Article

References (47)

1. Adams JR, Drake RE (2006) Shared decision-making and evidence-based practice. Community Ment Health J 42(1): 87-105.
2. Adler L, Shaw D, Sitt D, Maya E, Morrill I (2009) Issues in the diagnosis and treatment of adult ADHD by primary care physicians. Primary Psychiatry 16(5): 57-63.
3. American Psychiatric Association (APA) (2000) Diagnostic and statistical manual of mental disorders text revision, 4th edn. American Psychiatric Association, Washington.
4. Barkley RA, Fischer M, Smallish L, Fletcher K (2006) Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 45(2): 192-202.
5. Biederman J, Faraone SV (2005) Attention-deficit hyperactivity disorder. Lancet 366(9481): 237-248.
6. Biederman J, Petty CR, Woodworth KY, Lomedico A, Hyder LL, Faraone SV (2012) Adult outcome of attention-deficit/hyperactivity disorder: a controlled 16-year follow-up study. J Clin Psychiatry 73(7): 941-950.
7. Braddock CH III, Edwards KA, Hasenberg NM, Laidley TL, Levinson W (1999) Informed decision making in outpatient practice: time to get back to basics. JAMA 282(24): 2313-2320.
8. Brinkman WB, Hartl J, Rawe LM, Sucharew H, Britto MT, Epstein JN (2011) Physicians' shared decision-making behaviors in attention-deficit/hyperactivity disorder care. Arch Pediatr Adolesc Med 165(11): 1013-1019.
9. Cooper-Patrick L, Gallo JJ, Gonzales JJ, Vu HT, Powe NR, Nelson C, Ford DE (1999) Race, gender, and partnership in the patient-physician relationship. JAMA 282(6): 583-589.
10. Deber RB (1994) Physicians in health care management: 8. The patient-physician partnership: decision making, problem solving and the desire to participate. CMAJ 151(4): 423-427.
11. Elia J, Ambrosini PJ, Rapoport JL (1999) Treatment of attention-deficit-hyperactivity disorder. N Engl J Med 340(10): 780-788.
12. Fiks AG, Hughes CC, Gafen A, Guevara JP, Barg FK (2011) Contrasting parents' and pediatricians' perspectives on shared decision-making in ADHD. Pediatrics 127(1): e188-e196.
13. Goodman DW, Surman CB, Scherer PB, Salinas GD, Brown JJ (2012) Assessment of physician practices in adult attention-deficit/hyperactivity disorder. Prim Care Companion CNS Disord 14(4). pii: PCC11m01312. doi: 10. 4088/PCC. 11m01312.
14. Goss C, Moretti F, Mazzi MA, Del PL, Rimondini M, Zimmermann C (2008) Involving patients in decisions during psychiatric consultations. Br J Psychiatry 193(5): 416-421.
15. Hamann J, Leucht S, Kissling W (2003) Shared decision making in psychiatry. Acta Psychiatr Scand 107(6): 403-409.
16. Hinnenthal JA, Perwien AR, Sterling KL (2005) A comparison of service use and costs among adults with ADHD and adults with other chronic diseases. Psychiatr Serv 56(12): 1593-1599.
17. Hinshaw SP, Scheffler RM, Fulton BD, Aase H, Banaschewski T, Cheng W, Mattos P, Holte A, Levy F, Sadeh A, Sergeant JA, Taylor E, Weiss MD (2011) International variation in treatment procedures for ADHD: social context and recent trends. Psychiatr Serv 62(5): 459-464.
18. Hodgkins P, Montejano L, Sasane R, Huse D (2011) Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysis. Prim Care Companion CNS Disord 13(2): e1-e12.
19. Hooper R, Rona RJ, French C, Jones M, Wessely S (2005) Unmet expectations in primary care and the agreement between doctor and patient: a questionnaire study. Health Expect 8(1): 26-33.
20. Kaplan SH, Greenfield S, Ware JE Jr (1989) Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care 27(3 Suppl): S110-S127.
21. Kaye S, Darke S (2012) The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care? Addiction 107(3): 467-477.
22. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T, Ustun TB, Walters EE (2005) The World Health Organization adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 35(2): 245-256.
23. Kirkwood BR, Sterne JSC (2011) Essential medical statistics Malden, Massachusetts 02148-5020. Blackwell Science Ltd, USA.
24. Klein RG, Mannuzza S, Olazagasti MA, Roizen E, Hutchison JA, Lashua EC, Castellanos FX (2012) Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry 69(12): 1295-1303.
25. Kovshoff H, Vrijens M, Thompson M, Yardley L, Hodgkins P, Sonuga-Barke EJ, Danckaerts M (2013) What influences clinicians' decisions about ADHD medication? Initial data from the Influences on Prescribing for ADHD Questionnaire (IPAQ). Eur Child Adolesc Psychiatry [Epub ahead of print].
26. Kraemer M, Uekermann J, Wiltfang J, Kis B (2010) Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature. Clin Neuropharmacol 33(4): 204-206.
27. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1): 159-174.
28. Lensing MB, Zeiner P, Sandvik L, Opjordsmoen S (2013) Four-year outcome in psychopharmacologically treated adults with ADHD. J Clin Psychiatry 74(1): e87-e93.
29. Leon AC, Olfson M, Portera L, Farber L, Sheehan DV (1997) Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med 27(2): 93-105.
30. McCarthy S, Wilton L, Murray M, Hodgkins P, Asherson P, Wong IC (2013) Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners. Health Qual Life Outcomes 11(1): 22.
31. Michielsen M, Semeijn E, Comijs HC, Beekman AT, Deeg DJ, Kooij JJ (2012) Prevalence of attention-deficit hyperactivity disorder in older adults in The Netherlands. Br J Psychiatry: 201(4): 298-305.
32. Mongia M, Hechtman L (2012) Cognitive behavior therapy for adults with attention-deficit/hyperactivity disorder: a review of recent randomized controlled trials. Curr Psychiatry Rep 14(5): 561-567.
33. National Institute for Health and Clinical Excellence (2008) Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. Clinical guideline 72. Available at www. nice. org. uk/CG72.
34. Rafalovich A (2005) Exploring clinician uncertainty in the diagnosis and treatment of attention deficit hyperactivity disorder. Sociol Health Illn 27(3): 305-323.
35. Rohrbaugh M, Rogers JC (1994) What did the doctor do? When physicians and patients disagree. Arch Fam Med 3(2): 125-128.
36. Safren SA (2006) Cognitive-behavioral approaches to ADHD treatment in adulthood. J Clin Psychiatry 67(Suppl): 846-850.
37. Shaw K, Wagner I, Eastwood H, Mitchell G (2003) A qualitative study of Australian GPs' attitudes and practices in the diagnosis and management of attention-deficit/hyperactivity disorder (ADHD). Fam Pract 20(2): 129-134.
38. Simon V, Czobor P, Balint S, Meszaros A, Bitter I (2009) Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 194(3): 204-211.
39. Sobanski E, Bruggemann D, Alm B, Kern S, Deschner M, Schubert T, Philipsen A, Rietschel M (2007) Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 257(7): 371-377.
40. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP (1998) Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351(9100): 429-433.
41. Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A (2004) European clinical guidelines for hyperkinetic disorder-first upgrade. Eur Child Adolesc Psychiatry 13 Suppl: 117-130.
42. Taylor A, Deb S, Unwin G (2011) Scales for the identification of adults with attention deficit hyperactivity disorder (ADHD): a systematic review. Res Dev Disabil 32(3): 924-938.
43. Thapar A, Thapar A (2002) Is primary care ready to take on attention deficit hyperactivity disorder? BMC Fam Pract 3: 7.
44. The Norwegian Directorate of Health (2007) National guidelines for diagnosis and treatment of AD/HD (IS-1244 Veileder i diagnostikk og behandling av AD/HD) Oslo, Helsedirektoratet.
45. Torgersen T, Gjervan B, Rasmussen K, Vaaler A, Nordahl HM (2013) Prevalence of comorbid substance use disorder during long-term central stimulant treatment in adult ADHD. Atten Defic Hyperact Disord 5(1): 59-67.
46. Turgay A, Goodman DW, Asherson P, Lasser RA, Babcock TF, Pucci ML, Barkley R (2012) Lifespan persistence of ADHD: the life transition model and its application. J Clin Psychiatry 73(2): 192-201.
47. Waitzkin H (1984) Doctor-patient communication. Clinical implications of social scientific research. JAMA 252(17): 2441-2446.